These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37758321)

  • 1. Delusional infestation: a retrospective cohort study of 49 patients over a 6-year period.
    Hutchison E; Angus J; Davies J
    Clin Exp Dermatol; 2024 Jan; 49(2):146-148. PubMed ID: 37758321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of intensity of delusional belief in patients with delusional infestation pre- and post-treatment in a specialist psychodermatology center.
    Gkini MA; Nogueira J; Tanev T; Mohandas P; Taylor R; Bewley A
    J Dermatolog Treat; 2020 Sep; 31(6):602-605. PubMed ID: 30270706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review of antipsychotic agents for primary delusional infestation.
    McPhie ML; Kirchhof MG
    J Dermatolog Treat; 2022 Mar; 33(2):709-721. PubMed ID: 32658556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Understanding and Approach to Delusional Infestation.
    Moriarty N; Alam M; Kalus A; O'Connor K
    Am J Med; 2019 Dec; 132(12):1401-1409. PubMed ID: 31295443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delusional infestation treated with risperidone: a series of 27 patients.
    Guedes NLKO; Dwan AJ; Gerlero P; Nico MMS
    Clin Exp Dermatol; 2024 Mar; 49(4):364-367. PubMed ID: 38001055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delusional infestation: a clinical profile.
    Bhatia MS; Jhanjee A; Srivastava S
    Asian J Psychiatr; 2013 Apr; 6(2):124-7. PubMed ID: 23466108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of co-morbidities with prescribing patterns and cost savings: olanzapine versus risperidone for schizophrenia.
    Yu W; Ren XS; Lee AF; Herz L; Huang YH; Kazis LE
    Pharmacoeconomics; 2006; 24(12):1233-48. PubMed ID: 17129077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of mental health resources used by patients with bipolar disorder treated with risperidone, olanzapine, or quetiapine.
    Gianfrancesco F; Pesa J; Wang RH
    J Manag Care Pharm; 2005 Apr; 11(3):220-30. PubMed ID: 15804206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initiation of atypical antipsychotic agents and health outcomes in patients with schizophrenia.
    Ren XS; Lee AF; Huang YH; Hamed A; Herz L; Miller DR; Kazis LE
    J Clin Pharm Ther; 2004 Oct; 29(5):471-81. PubMed ID: 15482392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A patient with delusional infestation by proxy: Issues for vulnerable adults.
    Hussain K; Gkini MA; Taylor R; Shinhmar S; Bewley A
    Dermatol Ther; 2018 Nov; 31(6):e12724. PubMed ID: 30295380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight change over two years in people prescribed olanzapine, quetiapine and risperidone in UK primary care: Cohort study in THIN, a UK primary care database.
    Osborn DP; Petersen I; Beckley N; Walters K; Nazareth I; Hayes J
    J Psychopharmacol; 2018 Oct; 32(10):1098-1103. PubMed ID: 29938561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethnicity and prescription patterns for haloperidol, risperidone, and olanzapine.
    Opolka JL; Rascati KL; Brown CM; Gibson PJ
    Psychiatr Serv; 2004 Feb; 55(2):151-6. PubMed ID: 14762239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risperidone versus olanzapine in the acute treatment of Persistent Delusional Disorder: A retrospective analysis.
    Kulkarni K; Arasappa R; Prasad M K; Zutshi A; Chand PK; Murthy P; Philip M; Muralidharan K
    Psychiatry Res; 2017 Jul; 253():270-273. PubMed ID: 28411574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost of antipsychotic polypharmacy in the treatment of schizophrenia.
    Zhu B; Ascher-Svanum H; Faries DE; Correll CU; Kane JM
    BMC Psychiatry; 2008 Apr; 8():19. PubMed ID: 18394168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient characteristics and the likelihood of initiation on olanzapine or risperidone among patients with schizophrenia.
    Ren XS; Kazis LE; Lee AF; Huang YH; Hamed A; Cunningham F; Herz L; Miller DR
    Schizophr Res; 2005 Sep; 77(2-3):167-77. PubMed ID: 15894460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on the prescribing patterns of antipsychotic medication in a rural England Community Mental Health Team.
    Seshadri M; Elsemary A; Thalitaya MD; Chikodzore L; Nagalingam P
    Psychiatr Danub; 2017 Sep; 29(Suppl 3):524-529. PubMed ID: 28953820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsychotics for delirium.
    Lonergan E; Britton AM; Luxenberg J; Wyller T
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005594. PubMed ID: 17443602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.